Casey M. Tansey - 07 Aug 2025 Form 3 Insider Report for Heartflow, Inc. (HTFL)

Role
Director
Signature
/s/ Angela Ahmad, Attorney-in-Fact for Casey M. Tansey
Issuer symbol
HTFL
Transactions as of
07 Aug 2025
Net transactions value
$0
Form type
3
Filing time
07 Aug 2025, 21:14:19 UTC
Previous filing
05 Aug 2025
Next filing
16 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tansey Casey M Director C/O HEARTFLOW, INC., 331 E. EVELYN AVENUE, MOUNTAIN VIEW /s/ Angela Ahmad, Attorney-in-Fact for Casey M. Tansey 07 Aug 2025 0001474322

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HTFL Series B-1 Preferred Stock 07 Aug 2025 Common Stock 220,052 By U.S. Venture Partners X, L.P. F1, F2
holding HTFL Series B-1 Preferred Stock 07 Aug 2025 Common Stock 330,078 By U.S. Venture Partners X, L.P. F1, F2
holding HTFL Series B-1 Preferred Stock 07 Aug 2025 Common Stock 10,560 By USVP X Affiliates, L.P. F1, F2
holding HTFL Series B-1 Preferred Stock 07 Aug 2025 Common Stock 7,040 By USVP X Affiliates, L.P F1, F2
holding HTFL Series B-2 Preferred Stock 07 Aug 2025 Common Stock 220,052 By U.S. Venture Partners X, L.P. F1, F2
holding HTFL Series B-2 Preferred Stock 07 Aug 2025 Common Stock 330,078 By U.S. Venture Partners X, L.P F1, F2
holding HTFL Series B-2 Preferred Stock 07 Aug 2025 Common Stock 10,560 By USVP X Affiliates, L.P. F1, F2
holding HTFL Series B-2 Preferred Stock 07 Aug 2025 Common Stock 7,040 By USVP X Affiliates, L.P F1, F2
holding HTFL Series C Preferred Stock 07 Aug 2025 Common Stock 665,623 By U.S. Venture Partners X, L.P F2, F3
holding HTFL Series C Preferred Stock 07 Aug 2025 Common Stock 21,295 By USVP X Affiliates, L.P F2, F3
holding HTFL Series D Preferred Stock 07 Aug 2025 Common Stock 10,106 By U.S. Venture Partners X, L.P. F2, F4
holding HTFL Series D Preferred Stock 07 Aug 2025 Common Stock 80,855 By U.S. Venture Partners X, L.P. F2, F4
holding HTFL Series D Preferred Stock 07 Aug 2025 Common Stock 323 By USVP X Affiliates, L.P. F2, F4
holding HTFL Series D Preferred Stock 07 Aug 2025 Common Stock 2,586 By USVP X Affiliates, L.P. F2, F4
holding HTFL Series F Preferred Stock 07 Aug 2025 Common Stock 1,164,179 By U.S. Venture Partners X, L.P. F2, F5
holding HTFL Series F Preferred Stock 07 Aug 2025 Common Stock 37,244 By USVP X Affiliates, L.P. F2, F5
holding HTFL Convertible Promissory Note 07 Aug 2025 Common Stock $786,400 By U.S. Venture Partners X, L.P. F2, F6
holding HTFL Convertible Promissory Note 07 Aug 2025 Common Stock $25,158 By USVP X Affiliates, L.P. F2, F7
holding HTFL Convertible Promissory Note 07 Aug 2025 Common Stock $250,000 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B-1 preferred stock and Series B-2 preferred stock is convertible on a 1-to-0.4031 basis into shares of Heartflow, Inc.'s ("Heartflow") common stock and has no expiration date. The Series B-1 preferred stock and Series B-2 preferred stock will automatically convert into the underlying shares of common stock upon the closing of Heartflow's initial public offering. The conversion rate gives effect to the 1-for-2.92 reverse stock split of Heartflow's common stock, which became effective on July 31, 2025.
F2 Presidio Management Group X, L.L.C. ("PMG X") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 Each share of Series C preferred stock is convertible on a 1-to-0.5764 basis into shares of Heartflow's common stock and has no expiration date. The Series C preferred stock will automatically convert into the underlying shares of common stock upon the closing of Heartflow's initial public offering. The conversion rate gives effect to the 1-for-2.92 reverse stock split of Heartflow's common stock, which became effective on July 31, 2025.
F4 Each share of Series D preferred stock is convertible on a 1-to-0.6467 basis into shares of Heartflow's common stock and has no expiration date. The Series D preferred stock will automatically convert into the underlying shares of common stock upon the closing of Heartflow's initial public offering. The conversion rate gives effect to the 1-for-2.92 reverse stock split of Heartflow's common stock, which became effective on July 31, 2025.
F5 Each share of Series F preferred stock is convertible on a 1-to-0.3425 basis into shares of Heartflow's common stock and has no expiration date. The Series F preferred stock will automatically convert into the underlying shares of common stock upon the closing of Heartflow's initial public offering. The conversion rate gives effect to the 1-for-2.92 reverse stock split of Heartflow's common stock, which became effective on July 31, 2025.
F6 Represents the outstanding principal amount of a convertible promissory note held by U.S. Venture Partners X, L.P., which will automatically convert upon consummation of Heartflow's initial public offering into shares of common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. These shares of common stock issuable upon conversion of the convertible promissory note have no expiration date.
F7 Represents the outstanding principal amount of a convertible promissory note held by USVP X Affiliates, L.P., which will automatically convert upon consummation of Heartflow's initial public offering into shares of common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. These shares of common stock issuable upon conversion of the convertible promissory note have no expiration date.
F8 Represents the outstanding principal amount of a convertible promissory note held by Mr. Tansey, which will automatically convert upon consummation of Heartflow's initial public offering into shares of common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. These shares of common stock issuable upon conversion of the convertible promissory note have no expiration date.

Remarks:

Exhibit 24 - Power of Attorney.